文献速递慢性肾脏病

1999-2019年美国合并与不合并慢性肾脏病成人的全因死亡率趋势

National All-Cause Mortality Trends Among Adults With and Without CKD in the United States, 1999-2019.
PubMed 文献 · Am J Kidney Dis · 2026-03-23

结果显示CKD患者年龄标化死亡率从1999-2004年的23.0/1000人年降至2011-2016年的21.8/1000人年(APC -0.4%),总体稳定但约为无CKD成人的2倍,且女性死亡率上升而男性下降。

要点

  • CKD患者全因死亡率在1999-2019年间总体稳定,但始终约为无CKD者的2倍。
  • 女性CKD患者死亡率呈上升趋势(APC 2.3),而男性下降(APC -3.0)。
  • 需针对特定人群制定重点公共卫生策略以缩小死亡率差异。

核心结论

  • CKD成人全因死亡率总体保持稳定,但约为无CKD成人的2倍。
  • 女性CKD患者死亡率上升,男性下降,提示存在性别差异。

研究设计与样本

  • CKD定义为eGFR<60 mL/min/1.73 m2或尿白蛋白肌酐比≥30 mg/g。

主要发现

  • CKD患者年龄标化死亡率1999-2004年为23.0/1000人年(95%CI 19.8-26.2),2011-2016年为21.8/1000人年(95%CI 18.8-24.9),APC -0.4%(95%CI -1.4至0.5)。
  • 男性CKD患者死亡率APC为-3.0(95%CI -3.5至-2.6),女性APC为2.3(95%CI 1.7-3.0)。
  • 所有时期CKD相关死亡的调整相对危险度约为无CKD者的2倍。

关键数值与推荐

  • CKD定义:eGFR<60 mL/min/1.73 m2或尿白蛋白肌酐比≥30 mg/g。
  • 年龄标化死亡率按1999-2004、2005-2010、2011-2016三个调查期估计。

临床怎么用

  • 临床应关注CKD患者尤其是女性患者的心血管风险管理以降低死亡风险。
  • 公共卫生策略需针对死亡率上升的特定人群进行重点干预。

局限性

  • NHANES横断面设计无法分析CKD进展或随访期间新发CKD。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) is one of the most highly prevalent chronic conditions in the United States and associated with a high risk of premature death, particularly from cardiovascular disease. However, contemporary national trends in all-cause mortality among adults with CKD in the United States remain unclear. This study examined trends in all-cause mortality among US adults with CKD from 1999 to 2019. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: Adults aged ≥20 years who participated in the 1999-2016 National Health and Nutrition Examination Survey (NHANES), with mortality follow-up through December 2019. EXPOSURE: CKD defined by an estimated glomerular filtration rate < 60 mL/min/1.73 m2 or a urinary albumin-creatinine ratio ≥ 30 mg/g. OUTCOME: All-cause mortality. ANALYTICAL APPROACH: Age-standardized all-cause mortality rates were estimated for 3 survey periods: 1999-2004, 2005-2010, and 2011-2016. Average percent change (APC) in age-standardized mortality and adjusted relative risk (RR) of CKD-associated mortality for each survey period were estimated. RESULTS: Age-standardized mortality rate was 23.0 deaths/1,000 person-years (95% CI, 19.8-26.2) among adults with CKD surveyed 1999-2004 and 21.8 deaths/1,000 person-years (95% CI, 18.8-24.9) for those surveyed 2011-2016 (APC, -0.4% [95% CI, -1.4 to 0.5]). In contrast to men whose mortality declined (APC, -3.0 [95% CI, -3.5 to -2.6]), mortality rates increased among women with CKD (APC, 2.3 [95% CI, 1.7-3.0]). Adjusted RRs for CKD-associated mortality remained approximately 2-fold higher compared with adults without CKD across all time periods. LIMITATIONS: The cross-sectional design of NHANES precludes analysis of CKD progression or incident CKD during follow-up. CONCLUSIONS: All-cause mortality remained stable among adults with CKD and was about 2 times higher than for those without CKD. However, increasing mortality trends in specific demographic subpopulations may indicate the need for focused public health strategies and further research to address and reduce mortality disparities.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Choi D, Xu F, Zaganjor I, et al. National All-Cause Mortality Trends Among Adults With and Without CKD in the United States, 1999-2019. Am J Kidney Dis. 2026. PMID: 41881385. doi:10.1053/j.ajkd.2026.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。